These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596 [TBL] [Abstract][Full Text] [Related]
37. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome. Deodhar A; Norden J; So Y; Bennett R J Rheumatol; 1996 Jul; 23(7):1292-4. PubMed ID: 8823710 [TBL] [Abstract][Full Text] [Related]
38. The potential use of ephedrine in Lambert-Eaton myasthenic syndrome : clinical and electrophysiological evaluation. Cereda C; Kuntzer T J Neurol; 2008 Aug; 255(8):1259-60. PubMed ID: 18535871 [No Abstract] [Full Text] [Related]
39. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. Rosenfeld MR; Wong E; Dalmau J; Manley G; Posner JB; Sher E; Furneaux HM Ann Neurol; 1993 Jan; 33(1):113-20. PubMed ID: 8494331 [TBL] [Abstract][Full Text] [Related]
40. 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS. Oh SJ; Claussen GG; Hatanaka Y; Morgan MB Muscle Nerve; 2009 Nov; 40(5):795-800. PubMed ID: 19722254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]